Market Overview

Uroplasty Provides Update on Reimbursement Coverage for PTNS Procedures Using Urgent PC Neuromodulation System

Uroplasty (NASDAQ: UPI) today provided an update on reimbursement coverage for Percutaneous Tibial Nerve Stimulation (PTNS) procedures delivered via the Company's Urgent® PC Neuromodulation System for treatment of overactive bladder (OAB) and associated symptoms of urinary urgency, urinary frequency and urge incontinence.

"The number of patients with insurance coverage for PTNS procedures delivered via our Urgent PC system continues to grow and presents us with the opportunity for sustainable strong growth," said Rob Kill, President & CEO.  "Based on the latest reimbursement developments, including the decision of National Government Services (NGS) to continue its existing non-coverage policy for PTNS, we anticipate Urgent PC will exit calendar 2013 with approximately 40 million Medicare lives under coverage, an increase from 37 million a year ago, and approximately 106 million private insurer lives under coverage, up from 87 million a year ago."

The Centers for Medicare and Medicaid Services (CMS)

See full press release

Posted-In: News Guidance Offerings Contracts Legal Management Global

 

Most Popular

Related Articles (UPI)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free